MILAN, April 28, 2025 (Korea Bizwire) - Olon Group, a leading global pharmaceutical CDMO, announces the appointment of Jérôme Bédier as CEO of its French entities and Andrea Conforto as M&S VP CDMO of Olon Biotech, the division dedicated to CDMO services for biologics. These appointments reinforce Olon's strategy to expand its capabilities in Antibody-Drug Conjugates [...]The post Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France appeared first on Be Korea-savvy.
Olon is an Italy-based CDMO that provides services such as process development and production of mAbs, enzymes, proteins, and drugs for the pharmaceutical industry.